Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial
2023 · Journal of the American Academy of Dermatology · 4 citations
https://doi.org/10.1016/j.jaad.2023.09.071